5F-APINACA
5F-APINACA (also known as 5F-AKB-48 or APINACA 5-fluoropentyl analog) is a synthetic cannabinoid of the APINACA series. It was first identified in South Korea and is available for sale as a grey area research chemical through online vendors.
Chemistry[edit]
5F-APINACA is a synthetic cannabinoid that has similar properties to natural cannabinoids such as delta-9-tetrahydrocannabinol (THC). It is part of the APINACA series and is the 5-fluoropentyl analog of APINACA. The chemical formula of 5F-APINACA is C23H30FN3O.
Pharmacology[edit]
The pharmacology of 5F-APINACA is largely unknown. However, it is known to act as a potent agonist for the CB1 receptor, which is the primary binding site of THC in the body. This suggests that 5F-APINACA may have similar psychoactive effects to THC, although this has not been confirmed in scientific studies.
Legal Status[edit]
The legal status of 5F-APINACA varies by country. In the United States, it is a Schedule I controlled substance. In the United Kingdom, it is a Class B drug under the Misuse of Drugs Act. In Canada, it is a Schedule II substance under the Controlled Drugs and Substances Act.
Health Risks[edit]
The health risks associated with 5F-APINACA are not well understood due to the lack of scientific research. However, synthetic cannabinoids in general are known to be associated with a range of adverse effects, including psychosis, seizures, and even death in extreme cases.
See Also[edit]
